Kecheng Li - 10 Jun 2021 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
Director
Signature
/s/ Jerome Wong, as Attorney-in-Fact
Issuer symbol
EKSO
Transactions as of
10 Jun 2021
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 20:34:11 UTC
Next filing
27 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Award $0 +18,265 +200% $0.000000 27,408 10 Jun 2021 Direct F1, F2
transaction EKSO Common Stock Award $0 +51,721 +189% $0.000000 79,129 09 Jun 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.
F2 This award of RSUs was granted effective June 10, 2021, the date of the Company's 2021 annual meeting of stockholders (the "First Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021 (the "Annual RSU Grant Program"). The RSUs were scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the First Grant Date, and accordingly fully vested on June 9, 2022, the date of the Company's 2022 annual meeting of stockholders.
F3 This award of RSUs was granted effective June 9, 2022, the date of the Company's 2022 annual meeting of stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next annual meeting of stockholders or the one-year anniversary of the Grant Date.

Remarks:

This Form 4 is being filed late due to inadvertent administrative error.